The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
Miao-Fang WuMei-Mei GuanChang-Hao LiuJie-Ying WuQun-Xian RaoJing LiPublished in: Cancer medicine (2019)
SCCA, FBG, and a combination of SCCA and FBG could acceptably predict CR following NACT. Pretreatment SCCA and FBG levels were independent prognostic factors. The combination of SCCA and FBG levels refined the prognostic stratification of LACC patients, which allowed the group of patients with the highest risk of recurrence and death to be identified.
Keyphrases
- prognostic factors
- blood glucose
- neoadjuvant chemotherapy
- squamous cell carcinoma
- locally advanced
- end stage renal disease
- glycemic control
- ejection fraction
- chronic kidney disease
- newly diagnosed
- lymph node
- rectal cancer
- sentinel lymph node
- peritoneal dialysis
- type diabetes
- insulin resistance
- prostate cancer
- robot assisted
- radical prostatectomy
- free survival
- lymph node metastasis